Search research articles
Contact Us
Filters
Showing results (51-60 of 63) with videos related to
Page
of 7
Sort By:
The Journal of Clinical Investigation
|
May 3, 2019
Thioredoxin-1 confines T cell alloresponse and pathogenicity in graft-versus-host disease
M Hanief Sofi, Yongxia Wu, Steven D Schutt, et al.
JCI Insight
|
May 19, 2017
Ceramide synthesis regulates T cell activity and GVHD development
M Hanief Sofi, Jessica Heinrichs, Mohammed Dany, et al.
Cellular & Molecular Immunology
|
January 27, 2021
STING negatively regulates allogeneic T-cell responses by constraining antigen-presenting cell function
Yongxia Wu, Chih-Hang Anthony Tang, Corey Mealer, et al.
Blood Advances
|
February 28, 2018
Inhibition of the IRE-1α/XBP-1 pathway prevents chronic GVHD and preserves the GVL effect in mice
Steven D Schutt, Yongxia Wu, Chih-Hang Anthony Tang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 11, 2020
Targeting the Complement Alternative Pathway Permits Graft Versus Leukemia Activity while Preventing Graft Versus Host Disease
Hung Nguyen, Ali Alawieh, David Bastian, et al.
JCI Insight
|
December 21, 2018
Complement C3a and C5a receptors promote GVHD by suppressing mitophagy in recipient dendritic cells
Hung Nguyen, Sandeepkumar Kuril, David Bastian, et al.
Leukemia
|
May 5, 2022
Ceramide synthase 6 impacts T-cell allogeneic response and graft-versus-host disease through regulating N-RAS/ERK pathway
M Hanief Sofi, Linlu Tian, Steven Schutt, et al.
Nature Communications
|
January 3, 2023
The splanchnic mesenchyme is the tissue of origin for pancreatic fibroblasts during homeostasis and tumorigenesis
Lu Han, Yongxia Wu, Kun Fang, et al.
Cell Reports
|
March 31, 2023
Targeting protein tyrosine phosphatases for CDK6-induced immunotherapy resistance
Xueliang Gao, Yongxia Wu, Joel M Chick, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 1, 2018
Targeting JAK2 reduces GVHD and xenograft rejection through regulation of T cell differentiation
Brian C Betts, David Bastian, Supinya Iamsawat, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 63) with videos related to
Sort By:
Page
of 7
The Journal of Clinical Investigation
|
May 3, 2019
Thioredoxin-1 confines T cell alloresponse and pathogenicity in graft-versus-host disease
M Hanief Sofi, Yongxia Wu, Steven D Schutt, et al.
JCI Insight
|
May 19, 2017
Ceramide synthesis regulates T cell activity and GVHD development
M Hanief Sofi, Jessica Heinrichs, Mohammed Dany, et al.
Cellular & Molecular Immunology
|
January 27, 2021
STING negatively regulates allogeneic T-cell responses by constraining antigen-presenting cell function
Yongxia Wu, Chih-Hang Anthony Tang, Corey Mealer, et al.
Blood Advances
|
February 28, 2018
Inhibition of the IRE-1α/XBP-1 pathway prevents chronic GVHD and preserves the GVL effect in mice
Steven D Schutt, Yongxia Wu, Chih-Hang Anthony Tang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 11, 2020
Targeting the Complement Alternative Pathway Permits Graft Versus Leukemia Activity while Preventing Graft Versus Host Disease
Hung Nguyen, Ali Alawieh, David Bastian, et al.
JCI Insight
|
December 21, 2018
Complement C3a and C5a receptors promote GVHD by suppressing mitophagy in recipient dendritic cells
Hung Nguyen, Sandeepkumar Kuril, David Bastian, et al.
Leukemia
|
May 5, 2022
Ceramide synthase 6 impacts T-cell allogeneic response and graft-versus-host disease through regulating N-RAS/ERK pathway
M Hanief Sofi, Linlu Tian, Steven Schutt, et al.
Nature Communications
|
January 3, 2023
The splanchnic mesenchyme is the tissue of origin for pancreatic fibroblasts during homeostasis and tumorigenesis
Lu Han, Yongxia Wu, Kun Fang, et al.
Cell Reports
|
March 31, 2023
Targeting protein tyrosine phosphatases for CDK6-induced immunotherapy resistance
Xueliang Gao, Yongxia Wu, Joel M Chick, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 1, 2018
Targeting JAK2 reduces GVHD and xenograft rejection through regulation of T cell differentiation
Brian C Betts, David Bastian, Supinya Iamsawat, et al.
Page
of 7